+

WO2005117859A3 - Diagnostic d'affection cardiovasculaire - Google Patents

Diagnostic d'affection cardiovasculaire Download PDF

Info

Publication number
WO2005117859A3
WO2005117859A3 PCT/US2005/016370 US2005016370W WO2005117859A3 WO 2005117859 A3 WO2005117859 A3 WO 2005117859A3 US 2005016370 W US2005016370 W US 2005016370W WO 2005117859 A3 WO2005117859 A3 WO 2005117859A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
cardiovascular disease
diagnosing cardiovascular
diagnosing
subject
Prior art date
Application number
PCT/US2005/016370
Other languages
English (en)
Other versions
WO2005117859A2 (fr
Inventor
Alessandro Doria
Xiaowei Ma
Original Assignee
Joslin Diabetes Center Inc
Alessandro Doria
Xiaowei Ma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Joslin Diabetes Center Inc, Alessandro Doria, Xiaowei Ma filed Critical Joslin Diabetes Center Inc
Priority to US11/248,578 priority Critical patent/US8080374B2/en
Publication of WO2005117859A2 publication Critical patent/WO2005117859A2/fr
Publication of WO2005117859A3 publication Critical patent/WO2005117859A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Medical Treatment And Welfare Office Work (AREA)

Abstract

Ces procédés visent à diagnostiquer un patient aux risques accrus d'affection cardiovasculaire.
PCT/US2005/016370 2004-05-11 2005-05-10 Diagnostic d'affection cardiovasculaire WO2005117859A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/248,578 US8080374B2 (en) 2004-05-11 2005-10-12 Methods of diagnosing cardiovascular disease

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56989804P 2004-05-11 2004-05-11
US60/569,898 2004-05-11

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/248,578 Continuation-In-Part US8080374B2 (en) 2004-05-11 2005-10-12 Methods of diagnosing cardiovascular disease

Publications (2)

Publication Number Publication Date
WO2005117859A2 WO2005117859A2 (fr) 2005-12-15
WO2005117859A3 true WO2005117859A3 (fr) 2006-04-20

Family

ID=35463320

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/016370 WO2005117859A2 (fr) 2004-05-11 2005-05-10 Diagnostic d'affection cardiovasculaire

Country Status (1)

Country Link
WO (1) WO2005117859A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100105088A1 (en) * 2007-02-05 2010-04-29 Aarhus Universitet method for diagnosing atherosclerotic plaques by measurement of cd36
WO2009128734A1 (fr) * 2008-04-18 2009-10-22 Vialactia Biosciences (Nz) Limited Identification assistée par un marqueur de mammifères ayant un caractère phénotypique souhaité

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
HANAWA H. ET AL: "Identification of Cryptic Splice Site, Exon Skipping, and Novel Point Mutations in type I CD36 Deficiency", JOURNAL OF MEDICAL GENETICS, vol. 39, no. 4, April 2002 (2002-04-01), pages 286 - 291, XP002995099 *
MA X. ET AL: "Common Haplotype At The CD36 Locus Is Associated With High Free Fatty Acid Levels And Increased Cardiovascular Risk In Caucasians", HUMAN MOLECULAR GENETICS, vol. 13, no. 19, October 2004 (2004-10-01), pages 2197 - 2205, XP002995100 *
TANAKA T. ET AL: "Defect in Human Myocardial Long-Chain Fatty Acid Uptake Is Caused by FAT/CD36 mutations", JOURNAL OF LIPID RESEARCH, vol. 42, no. 5, May 2001 (2001-05-01), pages 751 - 759, XP002995098 *

Also Published As

Publication number Publication date
WO2005117859A2 (fr) 2005-12-15

Similar Documents

Publication Publication Date Title
GB0401730D0 (en) Diagnosis method
GB2414190B (en) Golf swing diagnosing system
EP1806581A4 (fr) Systeme de diagnostic d'une maladie
HK1114171A1 (en) Copeptin-based diagnostic kit for disorders
WO2007061906A3 (fr) Diagnostic et moyens therapeutiques pour troubles cardio-vasculaires
GB2415834B (en) Completion assemblies.
IL181507A0 (en) Methods for making retinoids and uses thereof
WO2007106466A3 (fr) Bêta-2 microglobuline utilisée comme biomarqueur pour des maladies artérielles périphériques
EP1787116A4 (fr) Procedes d'evaluation des risques de developpement de maladies cardio-vasculaires
GB0406271D0 (en) Diagnostic test
WO2007038155A3 (fr) Methodes de diagnostic d'une maladie cardiovasculaire
WO2005117859A3 (fr) Diagnostic d'affection cardiovasculaire
GB0518925D0 (en) Decking, kit of parts for making decking, and method of assembling the decking
WO2006136928A8 (fr) Techniques non invasives de determination de l'etat cardio-vasculaire d'une personne
GB0418679D0 (en) Techniques for improving ultrasound contrast ratio
GB0408685D0 (en) Diagnostic method
AP2005003355A0 (en) Beverage kit and method for producing a non-fermented malt-beverage.
GB0413917D0 (en) Diagnostic method
GB0413915D0 (en) Diagnostic method
GB0400607D0 (en) Diagnostic method
AU2004905444A0 (en) Determining transaction values
AU2004904120A0 (en) Cash ram player
AU2004902596A0 (en) E.v.a.s
AU2004900330A0 (en) Diagnostic Kit
AU2004905443A0 (en) Swaging Machine

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 11248578

Country of ref document: US

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWP Wipo information: published in national office

Ref document number: 11248578

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase
点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载